The oxalate phosphites are chemical compounds containing oxalate and phosphite anions. They are also called oxalatophosphites or phosphite oxalates. Oxalate phosphates can form metal organic framework compounds.
Related compounds include the nitrite oxalates, arsenite oxalates, [1] [2] phosphate oxalates and oxalatophosphonates.
The oxalate ion is rectangular and planar. The phosphite ion is shaped as a triangular pyramid. Because of high charge and stiff shape they will bridge across more than one cation, in particular those hard cations with a higher charge such as +3. Hydrogen can convert some of the oxygen on the anions to OH and reduce the charge. Many oxalate phosphite compounds have microporous structures where amines direct the structure formation. [3]
name | chem | mw | crystal system | space group | unit cell Å | volume | density | comment | references |
---|---|---|---|---|---|---|---|---|---|
peha = pentaethylenehexamine | [(H6peha)0.17(H2O)1.5][Al2(HPO3)2(C2O4)(HCOO)] | +formate | [4] | ||||||
(H13C5NOH)0.5(H2C13H14N2)0.25[Al2(HPO3)2(C2O4)(OH)(H2O)]0.5H2O | [4] | ||||||||
Li2(VOHPO3)2C2O4•6H2O | triclinic | P1 | a=6.3592, b=8.0789, c=9.1692, α=64.390°, β=87.277°, γ=67.624° | [5] | |||||
Li2(VOHPO3)2C2O4•4H2O | monoclinic | P21/a | a=6.3555 b=12.6368 c=9.0242 β=105.167° | [5] | |||||
Li2(VO)2(HPO3)2C2O4 | [6] | ||||||||
diammonium (μ-oxalato)-bis(μ-phosphonato)-dioxo-di-vanadium hydrate | (NH4)2(VOHPO3)2C2O4 2·9H2O | triclinic | P1 | a = 6.3844, b = 7.2278, c = 9.2965, α = 67.260°, β = 72.927°, γ = 85.848° | [7] | ||||
(μ6-Oxalato)-bis(μ4-hydrogen phosphonato)-bis(μ2-aqua)-bis(μ2-oxo)-di-sodium-di-vanadium | Na2(VO)2(HPO3)2C2O4 | 463.87 | triclinic | P1 | a 6.3255 b 6.7760 c 8.0759, α 104.992° β 101.679° γ 99.120° Z=1 | 319.20 | 2.413 | blue | [6] |
K2(VO)2(HPO3)2C2O4 | 514.10 | monoclinic | C2/c | a 17.75 b 6.370 c 13.977, β 115.42° Z=4 | 1427 | 2.393 | blue | [6] | |
K2MnII2(H2O)2C2O4(HPO3)2 | 472.09 | hexagonal | P63/m | a=9.7371 c=22.4924 | 1846.8 | 2.547 | pink | [8] | |
(CN3H6)2·Mn2.5(HPO3)(C2O4)2.5(H2O)·H2O | [9] | ||||||||
piperazine | [C4N2H12][MnII2(HPO3)2(C2O4)] | monoclinic | P21/c | a=6.0627 b=10.7122 c=10.387 β=97.956 Z=2 | 668.1 | 2.217 | pale pink | [10] | |
dab = 1,4-diaminobutane | H2dab·Mn2(HPO3)2(C2O4)(H2O)2 | monoclinic | P21/n | a = 5.616, b = 15.431, c = 9.445, β = 91.72(2)°, Z = 2 | 818.2 | [11] | |||
ethylenediammonium manganese phosphite-oxalate | [C2N2H10][Mn2II(OH2)2(HPO3)2(C2O4)] | monoclinic | P21/c | a 7.837 b 8.755 c 10.100, β 100.605° | [12] | ||||
bis(1-(3-ammoniopropyl)imidazolium) tetrakis(μ-dihydrogen phosphato)-tetrakis(μ-oxalato)-tetra-manganes | H2api·Mn2(H2PO4)2(C2O4)2 | triclinic | P1 | a=7.6108 b=9.8476 c=15.2437, α=100.023° β=102.032° γ=110.612° | [13] | ||||
(C6H14N2)0.5Mn(H2PO3)(C2O4) | [14] | ||||||||
1,4-diazabicyclo[2.2.2]octane (DABCO) | [C6N2H14]2[FeIII2F2(HPO3)2(C2O4)2]·2H2O | monoclinic | P21/n | a=12.51 b=6.372 c=33.153 β=90.532 Z=4 | 2643.0 | 1.875 | colourless; chains | [15] | |
TREN | [C6N4H21]2[FeII4(HPO3)2(C2O4)5]·5H2O | triclinic | P1 | a=8.719 b=8.827 c=15.908 α=78.617 β=84.047 γ=68.241 Z=2 | 1114.1 | 1.770 | brown; network | [15] | |
[FeIII2(OH2)2(HPO3)2(C2O4)]·H2O | monoclinic | P21/c | a=4.875 b=17.707 c=6.984 β=106.728 Z=4 | 577.46 | 2.368 | colourless | [15] | ||
ethylenediammonium | [C2N2H10][FeII2(OH2)2(HPO3)2(C2O4)] | monoclinic | P21/c | a=7.684 b=8.651 c=10.053 β=100.821 Z=4 | 653.6 | 2.317 | brown | [15] | |
BAPEN | [C8N4H26][FeIII6(HPO3)8(C2O4)3]·4H2O | monoclinic | P21/n | a=8.493 b=16.685 c=16.215 β=95.919 Z=4 | 2280.35 | 2.157 | colourless | [15] | |
homopip | [C5N2H14][FeII4(HPO3)2(C2O4)3] | monoclinic | P21/c | a=7.682 b=7.726 c=18.092 β=94.443 Z=4 | 1070.8 | 2.004 | brown | [15] | |
Piperazinediium bis(μ4-phosphito)-(μ4-oxalato)-bis(μ3-oxalato)-tetra-iron(ii) | [C4N2H12][FeII4(HPO3)2(C2O4)3] | monoclinic | P21/c | a 7.7286 b 7.587 c 17.9816 β 98.214° | [16] | ||||
dab = 1,4-diaminobutane | (H2dab)0.5·Co(H2PO3)(C2O4) | [17] | |||||||
[C4N2H12][Co4(HPO3)2(C2O4)3] | monoclinic | P21/c | a=7.614 b=7.51 c=17.750 β=97.351 Z=2 | 1007.3 | 2.466 | [18] | |||
CN3H6·Co(H2PO3)(C2O4) | [8] | ||||||||
Co(H2PO3)(C2O4)·(C2H8N) | triclinic | P1 | [19] | ||||||
Co(H2PO3)(C2O4)·(C2H8N) | monoclinic | P21/n | [19] | ||||||
Co2(H2PO3)2(C2O4)3(C6N2H16)2 | monoclinic | P21/c | a=5.8605 b=13.6144 c=19.361 β=105.582 | 1487.9 | 1.733 | pink | [20] | ||
Co2(H2PO3)2(C2O4)2(C6N2H16) | monoclinic | P21/c | a=15.3007 b=8.2832 c=16.2601 β=113.487 Z=2 | 1890 | 2.010 | pink; proton conductor | [20] | ||
(C4H14N2)0.5Co(HPO3)(C2O4) | [14] | ||||||||
bis(1,4-Diazoniabicyclo[2.2.2]octane) bis(μ3-hydrogen phosphito)-dihydroxy-bis(oxalato)-di-gallium(iii) dihydrate | (C6N2H14)2[Ga2(OH)2(C2O4)2(HPO3)2]·2H2O | monoclinic | P21/n | a 12.401 b 6.283 c 33.306 β 91.197° | [21] | ||||
N,N,N',N'-Tetramethylethylenediammonium bis(μ3-hydrogen phosphito)-(μ2-oxalato)-dihydroxy-di-gallium(iii) | (C6N2H18)0.5[Ga(OH)(C2O4)0.5(HPO3)] | triclinic | P1 | a 6.257 b 8.558 c 9.253, α 93.219° β 108.265° γ 106.956° | [21] | ||||
bis(μ3-Hydrogen phosphito)-(μ2-oxalato)-bis(1H-imidazole)-di-gallium(iii) | Ga(C2O4)0.5(C3N2H4)(HPO3) | monoclinic | P21/c | a 8.038 b 8.709 c 11.487, β 91.85° | [21] | ||||
Ga(HPO3)(C2O4)(C3N2H4)·(C3N2H5) | orthorhombic | Pnma | a=13.288, b=6.361, c=1.5364, Z=4 | [22] | |||||
[bis(1,4-dimethylpiperazinediium) tetrakis(μ2-phosphito)-tetrakis(μ2-hydrogen phosphito)-bis(μ2-oxalato)-tetra-gallium] | [Ga2(HPO3)2(H2PO3)2(C2O4)](C6N2H16) | monoclinic | P21/c | a =10.183 b=12.525 c=16.295 β=98.218° | [23] | ||||
[hemikis(1,4-dimethylpiperazinediium) bis(μ3-phosphito)-(μ2-hydrogen phosphito)-(μ2-oxalato)-di-gallium] | [Ga2(HPO3)2(H2PO3)(C2O4)](C6N2H16)0.5 | monoclinic | C 2/c | a =23.462 b= 8.1170 c =16.898, β 112.873° | [23] | ||||
phen = 1,10-phenanthroline | Cd2(phen)2(H2PO4)(H2PO3)(C2O4) | chains | [17] | ||||||
Cd(C10H8N2)(HPO3)(C2O4)0.5 | [14] | ||||||||
catena-(Piperazinedi-ium bis(μ3-hydrogen phosphito)-(μ2-oxalato)-(μ2-hydrogen phosphito)-di-indium) | [C4H12N2][In2(HPO3)3(C2O4)] | orthorhombic | Cmcm | a=6.555 b=15.384 c=18.135 | [24] | ||||
[C4N2H12]3[In2(HPO3)2(C2O4)4].4H2O | [25] | ||||||||
1,4-diazabicyclo[2.2.2]octane (dabco) | C6H14N2[In2(HPO3)3(C2O4)] | 671.79 | orthorhombic | Pna21 | a = 12.414, b = 7.7166, c = 18.327, Z = 4 | 1755.6 | 2.542 | [26] | |
[C4N2H12]2[In2(HPO3)3(C2O4)2].3H2O | [25] | ||||||||
[C4N2H12]3[In4(HPO3)6(C2O4)3] | [25] | ||||||||
[C4N2H14][In4(H2O)(HPO3)5(C2O4)2].2H2O | [25] | ||||||||
H[In5(HPO3)6(H2PO3)2(C2O4)2]·(C4N2H11)2·H2O | triclinic | P1 | a =7.822 b =10.626 c =13.156, α =94.720° β =92.336° γ =110.181° | [27] | |||||
1-methylpiperazine | In5(HPO3)6(H1.5PO3)2(C2O4)2·(H2C5N2H12)2 | triclinic | P1 | a 10.1574 b 10.4440 c 10.6857, α 70.006° β 76.100° γ 79.337° | [28] | ||||
1-ethylpiperazine | In5(HPO3)6(H1.5PO3)2(C2O4)2·(H2C6N2H14)2 | triclinic | P1 | a 10.1904 b 10.4327 c 10.7158, α 69.373° β 77.185° γ 79.268° | [28] | ||||
dbu = 1,8-diazabicyclo[5.4.0]undec-7-ene | Hdbu·In2(HPO3)2(C2O4)1.5 | [17] | |||||||
Ba2(C2O4)(H2PO3)2 | 531.38 | monoclinic | C2/c | a = 12.3829, b = 7.9124, c = 11.0858, β=114.788 (2)°, Z = 4 | 986.10 | 3.534 | colourless | [29] | |
[Pr(H2O)(C2O4)0.5(HPO3)]·H2O | 300.93 | triclinic | P1 | a=6.6764 b=7.0684 c=7.8103 α=111.141° β=95.415° γ=90.457° Z=2 | 2.923 | [30] | |||
[Nd(H2O)(C2O4)0.5(HPO3)]·H2O | 304.26 | triclinic | P1 | a=6.6544 b=7.0684 c=7.8103 α=111.160° β=95.307° γ=90.590° Z=2 | 2.985 | [30] | |||
[Sm(H2O)(C2O4)0.5(HPO3)]·H2O | [30] | ||||||||
[Eu(H2O)(C2O4)0.5(HPO3)]·H2O | 311.98 | triclinic | P1 | a=6.5619 b=6.9442 c=7.7412 α=111.369° β=95.495° γ=90.824° Z=2 | 3.173 | [30] | |||
[Gd(H2O)(C2O4)0.5(HPO3)]·H2O | 317.27 | triclinic | P1 | a=6.5434 b=6.9311 c=7.7465 α=111.487° β=95.645° γ=90.833° Z=2 | 3.244 | [30] | |||
[Ho(H2O)(C2O4)0.5(HPO3)]·H2O | 324.95 | triclinic | P1 | a=6.4628 b=6.8519 c=7.6936 α=111.646° β=95.779° γ=91.028° Z=2 | 3.421 | [30] | |||
[Er(H2O)(C2O4)0.5(HPO3)]·H2O | 327.28 | triclinic | P1 | a=6.4400 b=6.8326 c=7.6747 α=111.654° β=95.757° γ=91.096° Z=2 | 3.487 | [30] | |||
[Tm(H2O)(C2O4)0.5(HPO3)]·H2O | triclinic | P1 | [30] | ||||||
[Yb(H2O)(C2O4)0.5(HPO3)]·H2O | 333.06 | triclinic | P1 | a=6.4075 b=6.8050 c=7.6647 α=111.753° β=95.858° γ=91.204° Z=2 | 3.589 | [30] | |||
[Lu(H2O)(C2O4)0.5(HPO3)]·H2O | triclinic | P1 | [30] | ||||||
Indium(III) sulfate (In2(SO4)3) is a sulfate salt of the metal indium. It is a sesquisulfate, meaning that the sulfate group occurs 11/2 times as much as the metal. It may be formed by the reaction of indium, its oxide, or its carbonate with sulfuric acid. An excess of strong acid is required, otherwise insoluble basic salts are formed. As a solid indium sulfate can be anhydrous, or take the form of a pentahydrate with five water molecules or a nonahydrate with nine molecules of water. Indium sulfate is used in the production of indium or indium containing substances. Indium sulfate also can be found in basic salts, acidic salts or double salts including indium alum.
Thorium oxalate is the inorganic compound with the formula Th(C2O4)2(H2O)4. It is a white insoluble solid prepared by the reaction of thorium(IV) salts with an oxalic acid. The material is a coordination polymer. Each Th(IV) center is bound to 10 oxygen centers: eight provided by the bridging oxalates and two by a pair of aquo ligands. Two additional water of hydration are observed in the lattice.
Basic lead phosphite is an inorganic compound with the proposed composition Pb3O(OH)2(HPO3). The compound contains the phosphite anion, which provides the reducing properties associated with the application of this material.
Caesium oxalate (standard IUPAC spelling) dicesium oxalate, or cesium oxalate (American spelling) is the oxalate of caesium. Caesium oxalate has the chemical formula of Cs2C2O4.
The sulfate fluorides are double salts that contain both sulfate and fluoride anions. They are in the class of mixed anion compounds. Some of these minerals are deposited in fumaroles.
The borophosphates are mixed anion compounds containing borate and phosphate anions, which may be joined together by a common oxygen atom. Compounds that contain water or hydroxy groups can also be included in the class of compounds.
Borate phosphates are mixed anion compounds containing separate borate and phosphate anions. They are distinct from the borophosphates where the borate is linked to a phosphate via a common oxygen atom. The borate phosphates have a higher ratio of cations to number of borates and phosphates, as compared to the borophosphates.
Selenogallates are chemical compounds which contain anionic units of selenium connected to gallium. They can be considered as gallates where selenium substitutes for oxygen. Similar compounds include the thiogallates and selenostannates. They are in the category of chalcogenotrielates or more broadly chalcogenometallates.
Sulfidostannates, or thiostannates are chemical compounds containing anions composed of tin linked with sulfur. They can be considered as stannates with sulfur substituting for oxygen. Related compounds include the thiosilicates, and thiogermanates, and by varying the chalcogen: selenostannates, and tellurostannates. Oxothiostannates have oxygen in addition to sulfur. Thiostannates can be classed as chalcogenidometalates, thiometallates, chalcogenidotetrelates, thiotetrelates, and chalcogenidostannates. Tin is almost always in the +4 oxidation state in thiostannates, although a couple of mixed sulfides in the +2 state are known,
Yttrium oxalate is an inorganic compound, a salt of yttrium and oxalic acid with the chemical formula Y2(C2O4)3. The compound does not dissolve in water and forms crystalline hydrates—colorless crystals.
The carbonate oxalates are mixed anion compounds that contain both carbonate (CO3) and oxalate (C2O4) anions. Most compounds incorporate large trivalent metal ions, such as the rare earth elements. Some carbonate oxalate compounds of variable composition are formed by heating oxalates.
The oxalate phosphates are chemical compounds containing oxalate and phosphate anions. They are also called oxalatophosphates or phosphate oxalates. Some oxalate-phosphate minerals found in bat guano deposits are known. Oxalate phosphates can form metal organic framework compounds.
A tellurite fluoride is a mixed anion compound containing tellurite and fluoride ions. They have also been called oxyfluorotellurate(IV) where IV is the oxidation state of tellurium in tellurite.
Manganese oxalate is a chemical compound, a salt of manganese and oxalic acid with the chemical formula MnC
2O
4. The compound creates light pink crystals, does not dissolve in water, and forms crystalline hydrates. It occurs naturally as the mineral Lindbergite.
A phosphate phosphite is a chemical compound or salt that contains phosphate and phosphite anions (PO33- and PO43-). These are mixed anion compounds or mixed valence compounds. Some have third anions.
Arsenide bromides or bromide arsenides are compounds containing anions composed of bromide (Br−) and arsenide (As3−). They can be considered as mixed anion compounds. They are in the category of pnictidehalides. Related compounds include the arsenide chlorides, arsenide iodides, phosphide bromides, and antimonide bromides.
Arsenide chlorides or chloride arsenides are compounds containing anions composed of chloride (Cl−) and arsenide (As3−). They can be considered as mixed anion compounds. They are in the category of pnictidehalides. Related compounds include the arsenide bromides, arsenide iodides, phosphide chlorides, and antimonide chlorides.
Niobium(V) oxalate is the hydrogen oxalate salt of niobium(V). The neutral salt has not been prepared.
Oxalate sulfates are mixed anion compounds containing oxalate and sulfate. They are mostly transparent, and any colour comes from the cations.
Europium compounds are compounds formed by the lanthanide metal europium (Eu). In these compounds, europium generally exhibits the +3 oxidation state, such as EuCl3, Eu(NO3)3 and Eu(CH3COO)3. Compounds with europium in the +2 oxidation state are also known. The +2 ion of europium is the most stable divalent ion of lanthanide metals in aqueous solution. Many europium compounds fluoresce under ultraviolet light due to the excitation of electrons to higher energy levels. Lipophilic europium complexes often feature acetylacetonate-like ligands, e.g., Eufod.
{{cite journal}}
: Cite journal requires |journal=
(help)